FDA eases ‘unnecessarily restrictive’ cancer clinical trial eligibility criteria
The FDA is addressing increasingly complex eligibility criteria in an effort to expand patient participation in cancer clinical trials, a move which will help shorten study recruitment timelines, among several other benefits to both researchers and...
